Table I.
DE-miRNAs in serum exosomes from healthy children, patients with KD and patients with KD following IVIG therapy.
| miRNA | N vs. KD (logFC) | KD vs. IVIG (logFC) |
|---|---|---|
| hsa-miR-4695-3p | 7.14 | −6.98 |
| hsa-miR-328 | 8.23 | −8.07 |
| hsa-miR-631 | 6.78 | −6.62 |
| hsa-miR-3190-5p | 6.45 | −6.29 |
| hsa-miR-574-3p | 6.30 | −6.15 |
| hsa-miR-1260a | 7.85 | −7.69 |
| hsa-miR-3622a-3p | 6.92 | −6.76 |
| hsa-miR-197-3p | 8.40 | −8.24 |
| hsa-miR-664-3p | 6.92 | −6.76 |
| hsa-miR-3622b-3p | 6.75 | −6.60 |
| hsa-miR-3613-3p | 6.46 | −6.30 |
| hsa-miR-33b-3p | 7.05 | −6.89 |
| hsa-miR-149-5p | 6.95 | −6.80 |
| hsa-let-7d-3p | 7.41 | −7.25 |
| hsa-miR-4780 | 6.50 | −6.34 |
| hsa-miR-204-5p | 6.95 | −6.79 |
| hsa-miR-3940-3p | 7.28 | −7.12 |
| hsa-miR-1227 | 7.09 | −6.94 |
| hsa-miR-937 | 6.20 | −6.04 |
| hsa-miR-4763-5p | 7.30 | −7.15 |
| hsa-miR-4713-5p | 6.22 | −6.06 |
| hsa-let-7b-3p | 7.47 | −7.31 |
| hsa-miR-211-5p | 7.15 | −6.99 |
| hsa-miR-4730 | 7.12 | −6.96 |
| hsa-miR-885-5p | 8.16 | −8.00 |
| hsa-miR-3184-3p | 6.17 | −6.01 |
| hsa-let-7e-3p | 6.25 | −6.10 |
| hsa-miR-644b-3p | 7.33 | −7.18 |
| hsa-miR-1909-5p | 6.39 | −6.23 |
| hsa-miR-483-3p | 6.85 | −6.69 |
| hsa-miR-4436b-5p | 7.77 | −7.61 |
| hsa-miR-5681b | 6.72 | −6.56 |
| hsa-miR-4646-3p | 6.27 | −6.11 |
| hsa-miR-1910 | 6.40 | −6.24 |
| hsa-miR-299-5p | 6.69 | −6.54 |
| hsa-miR-4312 | 6.83 | −6.68 |
| hsa-miR-449b-3p | 7.45 | −7.29 |
| hsa-miR-4701-5p | 7.97 | −7.82 |
| hsa-miR-1296 | 6.91 | −6.75 |
| hsa-miR-4728-3p | 7.45 | −7.29 |
| hsa-miR-4284 | 6.55 | −6.39 |
| hsa-miR-1976 | 6.65 | −6.49 |
| hsa-miR-4697-3p | 7.00 | −6.85 |
| hsa-miR-3714 | 6.38 | −6.22 |
| hsa-miR-5010-3p | 7.03 | −6.88 |
| hsa-miR-3141 | −7.30 | 7.33 |
| hsa-miR-134 | −6.45 | 6.40 |
| hsa-miR-4800-5p | −6.19 | 6.10 |
| hsa-miR-19b-3p | −6.50 | 6.79 |
| hsa-miR-4665-3p | −6.72 | 7.79 |
| hsa-miR-483-5p | −6.70 | 6.71 |
| hsa-miR-4463 | −7.07 | 6.13 |
| hsa-miR-1234 | −6.38 | 7.60 |
| hsa-miR-2392 | −6.91 | 6.38 |
| hsa-miR-22-3p | −6.71 | 6.44 |
| hsa-miR-4689 | −6.13 | 6.19 |
| hsa-miR-575 | −7.37 | 6.50 |
| hsa-miR-3911 | −6.30 | 6.75 |
| hsa-miR-191-3p | −6.06 | 7.44 |
| hsa-miR-1246 | −7.85 | 7.04 |
| hsa-miR-4271 | −6.83 | 6.26 |
| hsa-miR-671-5p | −8.16 | 6.14 |
| hsa-miR-3610 | −6.25 | 6.16 |
| hsa-miR-3156-5p | −6.40 | 7.17 |
| hsa-miR-4499 | −6.39 | 7.07 |
These miRNAs were the shared differentially expressed miRNAs of the comparisons between N and KD, and between KD and IVIG. DE-miRNAs, differentially expressed miRNAs; N, normal; KD, Kawasaki disease; IVIG, intravenous immunoglobulin; FC, fold change; miRNA or miR, microRNA.